Dan L Duncan Comprehensive Cancer Center
- Research works
- 64 ▲ 15% vs 2013–17
- Citations
- 3.2k 49.0 per fractional work
- Top-10% rate
- 10.6% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: Dan L Duncan Comprehensive Cancer Center is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.0×. Every wedge is a field page.
Which keywords describe research at Dan L Duncan Comprehensive Cancer Center?
By fractional works in all years, weighted toward what it does more of than the world: Breast Cancer, Chemotherapy, Immunotherapy, Cancer, Prognostic Factors, Transcriptional Regulation, Targeted Therapy and Clinical Trials.
- Molecular Subtypes
- Lymphoma
- Tumor Regression
- Metastatic Breast Cancer
- Cancer Risk
- Somatic Mutations
- Genomic Profiling
- Genomic Instability
- Precision Medicine
- Glucocorticoids
- Cancer Immunotherapy
- Survival Analysis
- Genetic Mutations
- Gene Expression
- Nuclear Receptors
- Biomarkers
- Clinical Trials
- Prognostic Factors
- Cancer
- Chemotherapy
- Breast Cancer
- Immunotherapy
- Inflammation
- Transcriptional Regulation
- Targeted Therapy
- Tumor Microenvironment
- Clinical Practice Guidelines
- Signaling
- Metastasis
- Receptor
- Estrogen
- Radiotherapy
- Neoadjuvant Therapy
- Molecular Characterization
- DNA Methylation
- Cancer Genomics
- Immunity
- Mutational Signatures
- Epigenetic Reprogramming
- Metastatic
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Breast Cancer6▲ 34×8 topics
- Chemotherapy6▲ 13×17 topics
- Immunotherapy6▲ 14×12 topics
- Cancer6▲ 6.5×30 topics
- Inflammation4▲ 2.5×28 topics
- Prognostic Factors4▲ 12×10 topics
- Transcriptional Regulation3▲ 21×8 topics
- Clinical Trials3▲ 7.5×9 topics
- Targeted Therapy3▲ 22×4 topics
- Biomarkers3▲ 7.1×8 topics
- Tumor Microenvironment3▲ 12×6 topics
- Nuclear Receptors3▲ 23×5 topics
- Clinical Practice Guidelines3▲ 7.1×8 topics
- Gene Expression3▲ 6.6×11 topics
- Signaling2▲ 34×3 topics
- Genetic Mutations2▲ 7.2×7 topics
- Metastasis2▲ 11×11 topics
- Survival Analysis2▲ 13×5 topics
- Receptor2▲ 47×2 topics
- Cancer Immunotherapy2▲ 23×3 topics
- Estrogen2▲ 43×1 topic
- Glucocorticoids2▲ 58×1 topic
- Radiotherapy2▲ 8.4×6 topics
- Precision Medicine2▲ 10×5 topics
- Neoadjuvant Therapy2▲ 13×4 topics
- Genomic Instability2▲ 22×2 topics
- Molecular Characterization2▲ 15×5 topics
- Genomic Profiling2▲ 26×2 topics
- DNA Methylation2▲ 22×3 topics
- Somatic Mutations2▲ 38×2 topics
- Cancer Genomics2▲ 43×1 topic
- Cancer Risk2▲ 8.8×4 topics
- Immunity2▲ 7.0×5 topics
- Metastatic Breast Cancer2▲ 34×2 topics
- Mutational Signatures2▲ 43×1 topic
- Tumor Regression2▲ 26×2 topics
- Epigenetic Reprogramming1▲ 28×2 topics
- Lymphoma1▲ 15×2 topics
- Metastatic1▲ 34×2 topics
- Molecular Subtypes1▲ 25×3 topics
Which research topics does Dan L Duncan Comprehensive Cancer Center publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Nutrition and Health in Aging, Childhood Cancer Survivors' Quality of Life and Acute Lymphoblastic Leukemia research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 1 works
- 2 Nutrition and Health in Aging Physiology 1 works
- 3 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 0 works
- 4 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 5 BRCA gene mutations in cancer Genetics 0 works
- 6 Breast Cancer Treatment Studies Cancer Research 0 works
- 7 Aortic Thrombus and Embolism Pulmonary and Respiratory Medicine 0 works
- 8 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 0 works
- 9 Cancer Cells and Metastasis Oncology 0 works
- 10 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Dan L Duncan Comprehensive Cancer Center's research output changed?
Output in 2018–2022 was 15% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Houston
- Waste Management (United States)
- APA Corporation (United States)
- Kinder Morgan (United States)
- EOG Resources (United States)
- K&L Gates (United States)
- ToxStrategies LLC (United States)
- NRG Energy (United States)
- Crown Castle International (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.